Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|June 10, 2026
In vitro activity of aztreonam/avibactam and comparators against Enterobacterales isolates from patients with hospital-acquired pneumonia, ventilator-associated pneumonia, and complicated intra-abdominal infections (ATLAS, 2021-2022)Qiwen Yang, Felipe Francisco Tuon, Sweta Shah, et al.International Journal of Environmental Research and Public Health|September 30, 2020
Reorienting Nurturing Care for Early Childhood Development during the COVID-19 Pandemic in Kenya: A ReviewConstance Shumba, Rose Maina, Gladys Mbuthia, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 25, 2012
Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor releasePadmini Jayaraman, Falguni Parikh, Esther Lopez-Rivera, et al.Cancer Research|January 9, 2014
Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2Esther Lopez-Rivera, Padmini Jayaraman, Falguni Parikh, et al.Cancer Research|August 30, 2018
Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8+ T Cells in Head and Neck CancerSri Krishna, Peaches Ulrich, Eric Wilson, et al.Oncoimmunology|October 6, 2018
TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapyPadmini Jayaraman, Falguni Parikh, Jared M Newton, et al.Nature Structural & Molecular Biology|September 23, 2024
Structural insights into CXCR4 modulation and oligomerizationKei Saotome, Luke L McGoldrick, Jo-Hao Ho, et al.Nature Communications|January 31, 2015
NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmesMaria Soledad Sosa, Falguni Parikh, Alexandre Gaspar Maia, et al.Journal for Immunotherapy of Cancer|August 15, 2019
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibitionJared M Newton, Aurelie Hanoteau, Hsuan-Chen Liu, et al.Cancer Research|October 17, 2014
Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancerFalguni Parikh, Dorothée Duluc, Naoko Imai, et al.Pageof 6